Stock listing
Okyo Pharma Limited
Selected listing: OKYO · NASDAQ · USD · US
Okyo Pharma Limited (NASDAQ:OKYO), Health Technology. Latest release Oct 6, 2026: OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial…
- Ticker
- NASDAQ:OKYO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Okyo Pharma Limited
The company is focused on developing innovative therapies for various medical conditions. Okyo Pharma aims to advance its research and product offerings in the pharmaceutical sector.
Latest news from Okyo Pharma Limited
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
October 5, 2026
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
October 5, 2026
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
October 6, 2026
OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences
September 28, 2026
OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences
September 28, 2026
Research Okyo Pharma Limited
Alternate listings
OK11:GETTEX
DE · EUR
Alternate listing for Okyo Pharma Limited; the primary context on this page is OKYO:NASDAQ.
OKYO:BOATS
US · USD
Alternate listing for Okyo Pharma Limited; the primary context on this page is OKYO:NASDAQ.
OK11:MUN
DE · EUR
Alternate listing for Okyo Pharma Limited; the primary context on this page is OKYO:NASDAQ.